×

Loxo stock soars on drug trial results: CEO

Monday, 5 Jun 2017 | 12:32 PM ET

CNBC's Meg Tirrell talks to Joshua Bilenker, CEO of Loxo Oncology, about the company's stock up 50% on the successful cancer drug trial live from the ASCO conference.